Hemorheologic profile in systemic sclerosis -: Role of NOS3-786T>C and 894G>T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease

被引:16
作者
Fatini, Cinzia
Mannini, Lucia
Sticchi, Elena
Rogai, Veronica
Guiducci, Serena
Conforti, Maria Letizia
Cinelli, Marina
Pignone, Alberto Moggi
Bolli, Paola
Abbate, Rosanna
Cerinic, Marco Matucci
机构
[1] Univ Florence, Dept Med & Surg Crit Care, Thrombosis Ctr, I-50134 Florence, Italy
[2] Univ Florence, AOU, Careggi, Italy
[3] IRCCS, Fdn Don Carlo Gnocchi ONLUS, Ctr S Maria Ulivi, Florence, Italy
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 07期
关键词
D O I
10.1002/art.21933
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Microvascular disorders are relevant in systemic sclerosis (SSc). Hyperviscosity, due to alterations of blood cells and plasma components, may play a role in the pathogenesis of microcirculatory disorders. An impaired availability of nitric oxide, related to polymorphisms in NOS3, the gene for endothelial cell nitric oxide synthase, might influence erythrocyte deformability. We undertook this study to investigate the hemorheologic profile in SSc and the role of NOS3 polymorphisms in modulating the hemorheologic status of SSc patients. Methods. We studied 113 consecutive SSc patients (75 with limited cutaneous SSc [IcSSc] and 38 with diffuse cutaneous SSc [dcSSc]) and 113 healthy controls. The hemorheologic profile was obtained by assessing whole blood viscosity (WBV; at shear rates of 0.512 and 94.5 seconds(-1)), plasma viscosity (PLV; at a shear rate of 94.5 seconds(-1)), and erythrocyte deformability index (DI). We determined NOS3 polymorphisms by molecular analysis. Results. A marked alteration of hemorheologic parameters was found both in patients with IcSSc and in those with dcSSc compared with controls (P < 0.0001). In multivariate analysis, rheologic variables were significantly associated with the disease (for WBV at a shear rate of 94.5 seconds(-1), odds ratio [OR] 5.4, 95% confidence interval [95% CI] 1.4-19.9, P = 0.01; for PLV, OR 2.8, 95% CI 1.2-6.5, P = 0.01; for DI, OR 3.9, 95% CI 1.4-10.8, P = 0.007), and NOS3 -786C and 894T alleles significantly affected the DI (for -786C allele, OR 2.3, 95% CI 1.01-5.4, P = 0.04, for 894T allele, OR 2.2, 95% CI 1.01-4.8, P = 0.04). The simultaneous presence of the -786C and 894T alleles represented a susceptibility factor for SSc (OR 2.8, 95% CI 1.4-5.7. P = 0.004). Conclusion. Our findings document an altered rheologic profile in SSc and demonstrate a relationship between this alteration and NOS3 polymorphisms, thus shedding light on a potential novel mechanism influencing the microcirculation in this disease.
引用
收藏
页码:2263 / 2270
页数:8
相关论文
共 47 条
  • [1] Lack association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients
    Allanore, Y
    Borderie, D
    Lemaréchal, H
    Ekindjian, OG
    Kahan, A
    [J]. CLINICA CHIMICA ACTA, 2004, 350 (1-2) : 51 - 55
  • [2] Low levels of nitric oxide (NO) in systemic sclerosis:: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells
    Allanore, Y
    Borderie, D
    Hilliquin, P
    Hernvann, A
    Levacher, M
    Lemaréchal, H
    Ekindjian, OG
    Kahan, A
    [J]. RHEUMATOLOGY, 2001, 40 (10) : 1089 - 1096
  • [3] Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis
    Assassi, S
    Mayes, MD
    McNearney, T
    Fischbach, M
    Reveille, JD
    Arnett, FC
    Tan, FK
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) : 907 - 911
  • [4] Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis
    Bateman, RM
    Jagger, JE
    Sharpe, MD
    Ellsworth, ML
    Mehta, S
    Ellis, CG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (06): : H2848 - H2856
  • [5] Genotyping method for point mutation detection in the endothelial nitric oxide synthase exon 7 using fluorescent probes. Clinical validation in systemic sclerosis patients
    Biondi, ML
    Marasini, B
    Leviti, S
    Turri, O
    Bernini, M
    Seminati, R
    Porreca, W
    Guagnellini, E
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (03) : 281 - 282
  • [6] Effects of nitric oxide on red blood cell deformability
    Bor-Kucukatay, M
    Wenby, RB
    Meiselman, HJ
    Baskurt, OK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (05): : H1577 - H1584
  • [7] Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease
    Cattaruzza, M
    Guzik, TJ
    Slodowski, W
    Pelvan, A
    Becker, J
    Halle, M
    Buchwald, AB
    Channon, KM
    Hecker, M
    [J]. CIRCULATION RESEARCH, 2004, 95 (08) : 841 - 847
  • [8] CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
  • [9] FLOW ACTIVATES AN ENDOTHELIAL POTASSIUM CHANNEL TO RELEASE AN ENDOGENOUS NITROVASODILATOR
    COOKE, JP
    ROSSITCH, E
    ANDON, NA
    LOSCALZO, J
    DZAU, VJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1663 - 1671
  • [10] Cotton SA, 1999, J PATHOL, V189, P273